
Suffering from Atopic Dermatitis?
Trial – Syneos Health/Eli Lilly Eli Lilly and Company are conducting a Long-term Study to Assess the Safety and Efficacy of xxxxxxxxxxx in Patients With Moderate-to-Severe
Trial – Syneos Health/Eli Lilly Eli Lilly and Company are conducting a Long-term Study to Assess the Safety and Efficacy of xxxxxxxxxxx in Patients With Moderate-to-Severe
Trial – Sun Pharma | IQVIA A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Efficacy and Safety of XXXXXXXXX in the Treatment of
Trial -Novartis A multicenter, double-blind, randomized withdrawal extension study of subcutaneous XXXXXXXXXX to demonstrate long-term efficacy, safety and tolerability in subjects with moderate to severe
Trial -DermTech A Multi-center Sample Collection Study in Patients with a variety of skin conditions including but not limited to Melanoma, Squamous Cell Carcinoma, and
Trial -ICON/Trevi This 1 year study aims to determine the evaluate the safety, tolerability, and effectiveness of nalbuphine as a treatment for the itching related
Trial – Castle Biosciences Prospective Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma
Trial – DermTech A Multi-center Sample Collection Study in Patients with Suspected Melanoma Utilizing DermTech’s Non-invasive Adhesive Patch Biopsy Kits To participate in your local
Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.